Skip to content

Insider · CIK 0001467437

Elizabeth D Phillips

officer

Files at KEQU (KEWAUNEE SCIENTIFIC CORP /DE/). First filing Dec 18, 2024, latest Oct 2, 2025.

Elizabeth D Phillips files SEC Form 4 as officer at KEQU (KEWAUNEE SCIENTIFIC CORP /DE/). Since Dec 18, 2024, Elizabeth D Phillips has reported 0 open-market buys worth $0 and 2 open-market sells worth $397k, the latest filed on Oct 2, 2025.

A track record needs three past buys with six months of prices behind them; Elizabeth D Phillips has 0, so none is measured yet.

The newest scored trade: sold $297k of KEQU on Oct 2, 2025, filed Oct 2, 2025, scored 54 (moderate).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $397k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

KEQU: KEWAUNEE SCIENTIFIC CORP /DE/

KEQUOct 9, 2026 · close 33.79

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
54Moderate
KEQUsell 3
KEWAUNEE SCIENTIFIC CORP /DE/
$297k
6,880 shares
-45%+40% from low-38% from high
45Moderate
KEQUsell 5
KEWAUNEE SCIENTIFIC CORP /DE/
$100k
1,850 shares
-12%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Oct 1, 2025 KEQU
Kewaunee Scientific Corporation
6,880
0.24% of outstanding
$293kOct 1, 2025none
Dec 17, 2024 KEQU
KEWAUNEE SCIENTIFIC CORP /DE/
1,850
0.06% of outstanding
$101kDec 17, 2024none

Transactions

Every row this insider has filed, 10 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 24, 2026KEQU
KEWAUNEE SCIENTIFIC CORP /DE/
AGrant or award
Restricted Stock Units FY27derivative
+2,466$0.00$02,466Jun 25, 2026
Oct 2, 2025KEQU
KEWAUNEE SCIENTIFIC CORP /DE/
SOpen-market sale
Common Stock
-6,877$43.20$297k8,251Oct 2, 2025
Oct 2, 2025KEQU
KEWAUNEE SCIENTIFIC CORP /DE/
SOpen-market sale
Common Stock
-3$44.20$1338,248Oct 2, 2025
Jun 30, 2025KEQU
KEWAUNEE SCIENTIFIC CORP /DE/
MOption exercise
Common Stock
+2,733$0.00$016,324Jul 2, 2025
Jul 1, 2025KEQU
KEWAUNEE SCIENTIFIC CORP /DE/
FTax withholding
Common Stock
-1,196$58.34$70k15,128Jul 2, 2025
Jun 30, 2025KEQU
KEWAUNEE SCIENTIFIC CORP /DE/
MOption exercise
Restricted Stock Units FY23derivative
-1,756$0.00$00Jul 2, 2025
Jun 30, 2025KEQU
KEWAUNEE SCIENTIFIC CORP /DE/
MOption exercise
Restricted Stock Units FY24derivative
-476$0.00$03,805Jul 2, 2025
Jun 30, 2025KEQU
KEWAUNEE SCIENTIFIC CORP /DE/
MOption exercise
Restricted Stock Units FY25derivative
-501$0.00$03,259Jul 2, 2025
Jun 25, 2025KEQU
KEWAUNEE SCIENTIFIC CORP /DE/
AGrant or award
Restricted Stock Units FY26derivative
+4,111$0.00$04,111Jun 27, 2025
Dec 17, 2024KEQU
KEWAUNEE SCIENTIFIC CORP /DE/
SOpen-market sale
Common Stock
-1,850$54.17$100k13,591Dec 18, 2024

Questions about Elizabeth D Phillips

Answered from the filings on this page, as of the latest one.

Is Elizabeth D Phillips buying or selling?

Not in the last 12 months. Elizabeth D Phillips's latest open-market trade on SEC Form 4 was sold $297k of KEQU on Oct 2, 2025.

How did Elizabeth D Phillips's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Elizabeth D Phillips has 0.

Where does Elizabeth D Phillips file Form 4?

Elizabeth D Phillips has filed Form 4 at KEQU (KEWAUNEE SCIENTIFIC CORP /DE/) as SVP, People & Culture. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.